After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
The stock has broken free of tiresome resistance in a big way.
Teva Pharmaceuticals (TEVA) stock is rising in early morning trading today after the company won antitrust approval to purchase Allergan's (AGN) generics business.
Cramer agrees with analysts' bullish calls on Gap and Allergan.
I expect Allergan or another player to bid for SGYP soon.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.